Effect of Unani compound formulation in the treatment of Knee joint osteoarthritis
Phase 2
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Registration Number
- CTRI/2021/03/031747
- Lead Sponsor
- ATIONAL INSTITUTE OF UNANI MEDICINE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Diagnosed case of OA Knee Joint as per ACR Criteria (Clinical and Radiological)
2.Patient of either gender.
3.Patients in age groups of 30-60years.
4.Radiologically Grade I,II, III and IV(Kellgren Lawrence grading scale) of OA Knee
Exclusion Criteria
1.Patients below 30years and above 60 years of age.
2.Systemic and metabolic illness like IHD,TB and Malignancy.
3.Patients with other than osteoarthritis
4.H/o Knee injury, surgery, steroid injection in knee joints
5.Pregnancy and lactation
6.Morbid Obesity BMI >40
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dose escalation by following assesment <br/ ><br>1.Reduction in Pain by using VAS <br/ ><br>2.Impoving quality of life assesed by WOMAC (modified) CRD PUNE <br/ ><br>Timepoint: Follow up:0th ,7th , 14th and 21st Day <br/ ><br>Duration of Protocol:21days. <br/ ><br>Duration of study:18 months <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Dose escalation by following assessment <br/ ><br>1.Reduction in Pain by using VAS <br/ ><br>2.Impoving quality of life assesed by WOMAC (modified) CRD PUNE <br/ ><br>Timepoint: Follow up:0th ,7th , 14th and 21st Day <br/ ><br>Duration of Protocol:21days. <br/ ><br>Duration of study:18 months <br/ ><br>If not responding well or adverse event stop the treatment and switchover to standard dose or other therapies